Loading organizations...
§ Private Profile · Grand Prairie, TX, USA
High-quality pharmaceutical products addressing key medical needs.
Neos Therapeutics has raised $74.1M across 3 funding rounds.
Neos Therapeutics has raised $74.1M in total across 3 funding rounds.
Neos Therapeutics has raised $74.1M in total across 3 funding rounds.
Neos Therapeutics's investors include Burrill Life Sciences Capital Fund III, CAC, Crabtree Partners, Delaware Street Capital, Essex Capital Corporation, Presidio Partners, Chad Norman, CMEA Capital.
Neos Therapeutics has raised $74.1M across 3 funding rounds. Most recently, it raised $20.6M Other Equity in February 2015.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 25, 2015 | $20.6M Venture Round | — | Burrill Life Sciences Capital Fund III, CAC, Crabtree Partners, Delaware Street Capital, Essex Capital Corporation, Presidio Partners | Announced |
| Apr 23, 2014 | $38M Debt Financing | Chad Norman | — | Announced |
| Mar 4, 2014 | $15.5M Series C | — | Burrill Life Sciences Capital Fund III, CAC, CMEA Capital, Crabtree Partners, Delaware Street Capital | Announced |